|本期目录/Table of Contents|

GNAS1 T393C基因多态性与实体瘤遗传易感性的Meta分析

《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]

期数:
2019年21期
页码:
3882-3886
栏目:
论著(精准医学)
出版日期:
2019-09-30

文章信息/Info

Title:
Relationship between GNAS1 T393C gene polymorphisms and genetic predisposition of solid tumors:A Meta-analysis
作者:
程 林孙凤军夏培元
陆军军医大学第一附属医院药学部,重庆 400038
Author(s):
Cheng LinSun FengjunXia Peiyuan
Department of Pharmacy,the First Affiliated Hospital of Army Medical University,Chongqing 400038,China.
关键词:
实体瘤GNAS1 T393C基因多态性遗传易感性Meta分析
Keywords:
solid tumorsGNAS1 T393Cgene polymorphismsgenetic predispositionMeta-analysis
分类号:
R730.231
DOI:
10.3969/j.issn.1672-4992.2019.21.035
文献标识码:
A
摘要:
目的:系统评价GNAS1 T393C基因多态性与实体瘤遗传易感性的关系。方法:检索《PubMed》、《Web of Science》、《Cochrane Library》、《Embase》、《中国期刊全文数据库》、《中国生物医学文献数据库》、《维普数据库》、《万方数据库》,收集研究GNAS1 T393C基因多态性与实体瘤遗传易感性文献,文献发表时间为自数据库建库以来至2018年8月。由两位评价员独立筛选文献、提取资料,采用stata 12.0统计软件进行Meta分析。结果:共纳入7项研究,包括1 313例实体瘤患者。Meta分析结果显示,携带GNAS1 T393C TT基因型和TC+CC基因型人群实体瘤的遗传易感性差异无统计学意义(P=0.292),携带GNAS1 T393C T等位和C等位基因人群实体瘤的遗传易感性差异无统计学意义(P=0.355)。亚组分析显示,携带GNAS1 T393C TT基因型和TC+CC基因型亚洲人和高加索人实体瘤的遗传易感性差异无统计学意义(P=0.245、P=0.521),携带GNAS1 T393C T等位和C等位基因亚洲人和高加索人实体瘤的遗传易感性差异无统计学意义(P=0.208、P=0.206);携带GNAS1 T393C TT基因型和TC+CC基因型人群泌尿生殖系统肿瘤的遗传易感性差异无统计学意义(P=0.300),携带GNAS1 T393C T等位和C等位基因人群泌尿生殖系统肿瘤的遗传易感性差异无统计学意义(P=0.266)。结论:GNAS1 T393C基因多态性与实体瘤遗传易感性无明显相关性。
Abstract:
Objective:To systematically evaluate the relationship between GNAS1 T393C gene polymorphisms and genetic predisposition of solid tumors.Methods:Databases including PubMed,Web of Science,Cochrance Library,Embase,Chineses Journals Full-text Database,China Biology Medicine disc,VIP Database,and Wanfang Database were searched to obtain the trails investigating relationship between GNAS1 T393C gene polymorphisms and genetic predisposition of solid tumors from the establishment of each database to August 2018.Two reviewers independently screened literature and extracted data,and evaluated the methodological quality of included studies.Then,Meta-analysis was performed using stata 12.0 software.Results:A total of 7 trials involving 1 313 patients with solid tumors were included.The results of Meta-analysis showed that,there was no statistically significant difference in genetic predisposition of solid tumors between patients with GNAS1 T393C TT genotype and TC+CC genotype (P=0.292),and there was no statistically significant difference in genetic predisposition of solid tumors between patients with GNAS1 T393C T allele and C allele (P=0.355).Subgroup analysis showed that there was no statistically significant difference in genetic predisposition of solid tumors between Asian and Caucasian with GNAS1 T393C TT genotype and TC+CC genotype (P=0.245,P=0.521),and there was no statistically significant difference in genetic predisposition of solid tumors between Asian and Caucasian with GNAS1 T393C T allele and C allele (P=0.208,P=0.206).There was no statistically significant difference in genetic predisposition of urogenital neoplasms between patients with GNAS1 T393C TT genotype and TC+CC genotype (P=0.300),and there was no statistically significant difference in genetic predisposition of urogenital neoplasms between patients with GNAS1 T393C T allele and C allele (P=0.266).Conclusion:There was no obvious correlation between GNAS1 T393C gene polymorphisms and genetic predisposition of solid tumors.

参考文献/References

[1]Arjumand W,Ahmad ST,Nafees S,et al.GNAS1(Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population:A case-control study[J].Genet Test Mol Biomarkers,2012,16(9):1062-1066.
[2]ZHANG PJ,CHEN YR,YAN DW,et al.Association between guanine nucleotide regulatory protein GNAS1 gene polymorphisms and genetic predisposition of solid tumors[J].Chin J Urol,2008,29(5):350-351.[张蓬杰,陈一戎,颜东文,等.鸟苷酸调节蛋白GNAS1基因多态性与膀胱癌遗传易感性[J].中华泌尿外科杂志,2008,29(5):350-351.]
[3]JIANG H,WANG C,ZHAO J,et al.Association between GNAS1 T393C gene polymorphisms and renal clear cell carcinoma risk[J].Medical Information,2013,26(12):112.[姜华,王辰,赵静,等.GNAS1 基因 T393C 多态性与肾透明细胞癌发病的相关性研究[J].医学信息,2013,26(12):112.]
[4]Alakus H,Monig SP,Warnecke-Eberz U,et al.Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer[J].World J Gastroenterol,2009,15(48):6061-6067.
[5]Watanabe M,Hirokawa Y,Tsuji M,et al.Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population[J].Anticancer Res,2008,28(6A):3711-3716.
[6]Otterbach F,Callies R,Frey UH,et al.The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma[J].Breast Cancer Res Treat,2007,105(3):311-317.
[7]Hahn S,Frey UH,Siffert W,et al.The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome[J].Eur J Endocrinol,2006,155(5):763-770.
[8]Shaid M.Genetics of pituitary adenomas[J].Neurology India,2017(3):577-587.
[9]Hida R.Duodenal neoplasms of gastric phenotype:An immunohistochemical and genetic study with a practical approach to the classification[J].The American Journal of Surgical Pathology,2017(3):343-353.
[10]Parish AJ,Nguyen V,Goodman AM,et al.GNAS,GNAQ,and GNA11 alterations in patients with diverse cancers[J/OL].Cancer,[2018-11-08].https://www.ncbi.nlm.nih.gov/pubmed/?term=30204251.
[11]Sugiura Y,Kanda H,Motoi N,et al.Osteosarcoma arising in fibrous dysplasia,confirmed by mutational analysis of GNAS gene[J].Pathol Res Pract,2018,214(2):318-324.
[12]Matsuo Y,Yamamoto H,Sato Y,et al.GNAS-mutated carcinoma arising from gastric foveolar metaplasia in the duodenum after 9 years of observation[J].Clin J Gastroenterol,2018,11(5):391-395.
[13]Klenke S,Siffert W.SNPs in genes encoding G proteins in pharmacogenetics[J].Pharmacogenomics,2011,12(5):633-654.
[14]Frey UH,Eisenhardt A,Lümmen G,et al.The T393C polymorphism of the G alpha S gene(GNAS1) is a novel prognostic marker in bladder cancer[J].Cancer Epidemiol Biomarkers Prev,2005,14(4):871-877.
[15]Frey UH,Lümmen G,Jager T,et al.The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma[J].Clin Cancer Res,2006,12(3 Pt 1):759-763.
[16]Gong HY,Hu WG,Wang XL,et al.TT genotype of GNAS1 T393C polymorphism predicts better outcome of advanced non-small cell lung cancer patients[J].World J Gastrointest Oncol,2014,6(12):444-449.
[17]Uzunoglu FG,Heumann A,Musici S,et al.The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer[J].Lung Cancer,2013,79(2):151-155.
[18]Xie FJ,Zhao P,Kou JY,et al.The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum[J].Cancer Chemother Pharmacol,2012,69(6):1443-1448.
[19]Vashist YK,Kutup A,Musici S,et al.The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer[J].Cell Oncol(Dordr),2011,34(4):281-288.
[20]Alakus H,Warnecke-Eberz U,Bollschweiler E,et al.GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer[J].Pharmacogenomics J,2009,9(3):202-207.
[21]Schmitz KJ,Lang H,Frey UH,et al.GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangio carcinoma[J].Neoplasia,2007,9(2):159-165.
[22]Lehnerdt GF,Franz P,Zaqoul A,et al.Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene[J].Clin Cancer Res,2008,14(6):1753-1758.
[23]GONG HY,SONG QB,HU WG,et al.Relationship single nueleotide polymorphisms of GNAS1 T393C and prognosis of advanced non-small cell lung cancer[J].J Chin Oncol,2017,23(1):20-24.[龚虹云,宋启斌,胡伟国,等.GNAS1 T393C多态性与晚期非小细胞肺癌生存的相关性研究[J].肿瘤学杂志,2017,23(1):20-24.]
[24]Tang Y,Song P,Lu W.The prognostic value of T393C-SNP of GNAS1 in patients with solid tumors[J].Int J Clin Exp Med,2016,9(2):2889-2896.

备注/Memo

备注/Memo:
重庆市社会事业与民生保障科技创新专项分课题(编号:cstc2016shms-ztcs 10004)
更新日期/Last Update: 2019-09-30